In an effort to educate the public, media and policymakers about clinical trials and the growing role of clinical research organizations in the drug development process, the Association of Clinical Research Organizations (ACRO) has launched a YouTube channel @ACROHealthChannel.
“Increasingly, the ACRO member companies constitute the global drug development infrastructure,” said John Lewis, ACRO Vice President of Public Affairs. “With a footprint now in 115 countries and responsibility for annually conducting more than 11,000 clinical trials involving two million participants, we have an obligation to engage and educate our various constituencies about issues effecting clinical research. These topics range from ensuring human subject protections to cultivating favorable regulatory and economic environments that promote more efficient drug development.”
The first two videos on ACROHealthChannel feature 2012 ACRO Chairman Jeff McMullen, President and CEO of PharmaNet/i3, discussing the association’s agenda for the year, and Neil McCollough, Vice President of Global Quality and Compliance at Pharmaceutical Product Development, LLC (PPD), discussing issues surrounding bioethics and the globalization of research.
“ACRO strives to be a resource for anyone in the world who is interested in clinical research and drug development,” said Lewis. “We find the ACROHealthChannel, our Twitter feed @acrohealth, and other social media to be effective communications tools to reach a broad audience.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.